Beijing Kreate Medical Co., Ltd. FDA Approvals

0 new drug approvals and 3 device clearances on file. This applicant is not matched to a listed company.

Newest first

A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.

Product	What it is	Route	Decided
Redermax® Antibacterial Wound Matrix510(k)Aug 14, 2026	—	510(k)Substantially Equivalent (Traditional)	Aug 14, 2026
Redermo Wound Matrix510(k)Apr 16, 2026	—	510(k)Substantially Equivalent (Traditional)	Apr 16, 2026
Redermax Antibacterial Wound Matrix510(k)Feb 2, 2026	—	510(k)Substantially Equivalent (Traditional)	Feb 2, 2026